Cullinan Therapeutics 株価情報 (NASDAQ: CGEM)

最新ニュース Cullinan Therapeutics (NASDAQ:CGEM) 株価情報

Cullinan Therapeutics

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics Inc

Capgemini SE

<ul>
<li>In an interview with CNN on Tuesday, Melinda French Gates criticized the recent trend of ultra-wealthy people getting involved in politics</li>
<li>She spoke to concerns that the U.S. is becoming an oligarchy, telling the host she "hopes" that's not where things are heading</li>
<li>The Pivotal Ventures founder also said that the ultra-wealthy have a "moral obligation" to use their money philanthropically&nbsp;</li>
</ul>
When President Donald Trump put together his cabinet at the beginning of his second term, he stocked it with uber-wealthy businessmen. From Treasury Secretary Scott Bessent, the former CEO of Key Square Capital Management who has a net worth north of $500 million, to Steve Feinberg, the deputy secretary of cefense and former CEO of Cerberus Capital Management whose net worth hovers around $5 billion, these appointments are the most recent examples of the ultra wealthy dipping their toes into politics.
Don't Miss:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
The migrations from boardrooms to Capitol Hill have many worried that the country is becoming an oligarchy. Now, Melinda French Gates, who has a <a href="https://www.bloomberg.com/billionaires/profiles/melinda-french-gates/">net worth of $14.5 billion</a>, is speaking out.
In an interview with <a href="https://www.youtube.com/watch?v=zc9pV2bimAo">CNN</a> on Tuesday, she was critical of the trend of wealthy individuals engaging in politics. Throughout the conversation with host Abby Phillip, French Gates reiterated her oft-espoused belief that "to whom much is given, much is expected," making it clear that she did not approve of the way many ultra-wealthy are currently pouring money into electing their preferred candidates or using their fortunes to buy themselves powerful positions.&nbsp;
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
In response to Phillip's inquiry about whether this political focus is new or has always existed in these sorts of upper-class circles, French Gates replied, "I think we are seeing some of their true personalities come out in the last few years. I think this has always been in the undertone of lots of people… I think some of the particular people you're seeing right now, the values that they espouse are just different than mine." Continuing, "I know a lot of these folks. I've met a lot of them."
And when asked point-blank if she thought the country was on the verge of becoming an oligarchy, she replied, "I hope not."
Instead of politics, French Gates would like to see her peers investing money in more charitable causes. In 2010, she started The Giving Pledge with then-husband Bill Gates and billionaire Warren Buffett. The initiative pushes the ultra-wealthy to donate at least half of their fortunes to charitable and philanthropic causes, either during their lifetimes or after death through their wills and endowments. "If you have a billion dollars, that's an absurd amount of wealth. You have a moral responsibility to give away at least half of it," French Gates said.&nbsp;
Read Next:
<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.</li>
<li><a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy">This investment company boasts a 33.85% internal rate of return (IRR) for its realized projects, allowing accredited investors to earn passive returns and avoid the headaches of being a landlord.</a></li>
</ul>
Image: Shutterstock

Personal Finance

'We Are Seeing Some Of Their True Personalities Come Out.' Melinda French Gates Speaks Out About The Rise of Billionaires In Politics

MCRB

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

FMTO

BSLK

BSLKW

Valero Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>) has outperformed the market over the past 5 years by 3.02% on an annualized basis producing an average annual return of 15.7%. Currently, Valero Energy has a market capitalization of $34.23 billion. 
Buying $100 In VLO: If an investor had bought $100 of VLO stock 5 years ago, it would be worth $209.03 today based on a price of $108.84 for VLO at the time of writing.
<h3>Valero Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745279111_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much You Would Have Made Owning Valero Energy Stock In The Last 5 Years

A Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) executive replied to a post on social media that called out the defense contractor for a <a href="https://www.benzinga.com/tech/25/04/44882049/peter-thiels-palantir-bags-30-million-order-from-ice-for-immigrant-tracking-system">new extended contract</a> with the Immigration and Customs Enforcement agency.
Here's what Palantir Global Head of Commercial Ted Mabrey had to say.
What Happened: Y Combinator co-founder Paul Graham criticized in a social media post the<a href="https://www.benzinga.com/markets/25/03/44209697/how-peter-thiel-and-elon-musk-are-shaping-trump-administration"> work being done</a> by Palantir to help the Trump administration in rounding up immigrants.
"It's a very exciting time in tech right now. If you're a first-rate programmer, there are a huge number of other places you can go work rather than at the company building the infrastructure of the police state," Graham <a href="https://x.com/MabreyTed/status/1913703425495470304">tweeted</a>.
Graham shared a post on the ICE contract with Palantir that will build "ImmigrationOS" to expand surveillance and enforcement operations.
Included in the post were highlights of ImmigrationOS providing data on via overstays, self-deportation cases and individuals flagged for removal, including "foreign students flagged for removal for protesting U.S.-Israeli genocide."
Mabrey said Palantir's work with the Department of Homeland Security has spanned the Obama, Trump and Biden administrations.
"We are not looking for partisans at Palantir. Our mission spans administrations and political climates and our culture is one of constant disagreement," Mabrey said.
The Palantir executive, who has been with the company since 2010 according to <a href="https://www.linkedin.com/in/ted-mabrey/">LinkedIn</a>, said immigration policies can't be executed by governments.
"If the electorate cannot steer the execution of our government because the government cannot execute, our institutions lose all credibility, and the risk moves from an X debate to a much more fundamental one."
Mabrey said Palantir hires "believers" and the company's work is hard and covers "all sides of the political aisle."
Read Also: <a href="https://www.benzinga.com/news/earnings/25/02/43449486/palantir-q4-earnings-revenue-beat-eps-beat-us-revenue-up-52-customer-count-up-43-strong-guidance-this-is-a-new-phase-unlike-anything-that-has-come-before">Palantir Q4 Earnings: Revenue Beat, EPS Beat, US Revenue Up 52%, Customer Count Up 43%, Strong Guidance</a>
Why It's Important: In the social media post, Mabrey highlights past work done by Palantir, such as protecting people in wars in Iraq and Afghanistan, helping with vaccines during Operation Warp Speed, helping with the Afghan withdrawal and enabling "David to resist Goliath in Ukraine."
"My politics have not agreed with many of the policies our software has enabled. But through all of them I have held the steadfast belief that if our government institutions are not competent, politics does not matter."
Graham replied asking if Mabrey and/or Palantir would commit publicly to not "build things that help the government violate the U.S. constitution."
Another lengthy post from Mabrey said this question from Graham was "in bad faith" and compared it to a courtroom trick.
Mabrey said the company's employee political makeup is "enormously varied."
"We make this promise as a company operating in America under the rule of law."
Mabrey's comment that he has not always agreed with things the company does could show the efforts Palantir makes on policies that are supported by both Republicans and Democrats. The company landed government contracts under various presidents and political parties.
Graham highlighted to another social media user that the point about protesting U.S.-Israeli genocide should be a red flag and is why he was most critical of Palantir's new contract extension with ICE.
Palantir stock has soared in the past year and the company was viewed as one of the many that could be favorable in a Trump administration with several connections to the company and the current presidential administration and donors.
Several Palantir co-founders <a href="https://www.benzinga.com/general/politics/24/06/39557155/palantir-co-founders-thiel-lonsdale-back-trump-in-2024-election-id-rather-have-him-than-biden">endorsed Trump for the</a> 2024 presidential election as well.
PLTR Price Action: Palantir stock was down 3.18% to $90.80 on Monday at market close versus a 52-week trading range of $20.36 to $125.41. Palantir stock is up 20.8% year-to-date in 2025 and up over 300% in the past year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/09/40795608/palantirs-s-p-500-journey-rebel-tech-giant-transforms-into-frankenstein-monster-powere">Palantir&#8217;s S&amp;P 500 Journey: Rebel Tech Giant Transforms Into &#8216;Frankenstein Monster Powered By Freak Show Leader&#8217;</a></li>
</ul>
Photo: slyellow via Shutterstock.com

Government

Social Media

Politics

Management

PLTR

Palantir Executive Defends Company's ICE Contract: 'All Sides Of The Political Aisle'

Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) has outperformed the market over the past 5 years by 3.58% on an annualized basis producing an average annual return of 16.25%. Currently, Carvana has a market capitalization of $26.28 billion. 
Buying $1000 In CVNA: If an investor had bought $1000 of CVNA stock 5 years ago, it would be worth $2,230.16 today based on a price of $195.60 for CVNA at the time of writing.
<h3>Carvana's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745278219_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CVNA

Here's How Much You Would Have Made Owning Carvana Stock In The Last 5 Years

Though UnitedHealth Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) reported disappointing first-quarter results last week, two analysts from KeyBanc Capital Markets and Truist Securities remain <a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44902410/unitedhealth-group-stock-is-getting-crushed-whats-fueling-the-selloff">bullish on the stock. </a>
Expert Ideas: Both David MacDonald at Truist and Matthew Gillmor at KeyBanc said that although the health care giant's most recent quarter and 2025 earnings guidance missed the mark, they remain bullish on UnitedHealth for the long term. 
Read Next:<a href="https://www.benzinga.com/general/health-care/25/04/44869920/unitedhealth-ceo-says-high-cost-of-us-health-care-simply-not-sustainable"> UnitedHealth CEO Says High Cost Of US Health Care &#8216;Simply Not Sustainable&#8217;&nbsp;</a>
Both analysts said that while the Medicare Advantage utilization trend was troubling, its emergence early in the year will allow time for management to correct course.&nbsp; When coupled with the better-than-expected rate updates for 2026, the analysts see the company recovering into 2026.&nbsp;
The Truist analyst highlighted the narrowing Medicaid rate mismatch and upbeat selling season commentary from management.
KeyBanc sees a "silver lining" in UnitedHealth's ability to correct the RAF coding issues for 2026 and expects the company to factor the higher utilization rates into June bids. The analyst also said competitors like Humana and CVS are "not well positioned to take advantage of UNH's stumble."&nbsp;
The Takeaway: The analysts see UnitedHealth's issues as mostly isolated and "fixable" and maintained bullish ratings on the stock while slashing price targets.&nbsp;
KeyBanc maintained an Overweight rating on UnitedHealth shares, but lowered its price target from $650 to $575. Truist Securities maintained its Buy rating and lowered the price target for UnitedHealth stock from $660 to $580. 
UNH Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro,</a> UnitedHealth shares ended Monday's session 6.35% lower at $425.33. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/04/44903087/amazon-stock-downgraded-price-target-slashed-as-tariffs-create-uncertainty">Amazon Stock Downgraded, Price Target Slashed As Tariffs Create Uncertainty&nbsp;</a></li>
</ul>

Earnings

Health Care

Price Target

Analyst Ratings

General

UnitedHealth Q1 Disappoints, But These Analysts Remain Bullish On The Stock

Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) has outperformed the market over the past 15 years by 7.75% on an annualized basis producing an average annual return of 18.03%. Currently, Lululemon Athletica has a market capitalization of $30.67 billion. 
Buying $100 In LULU: If an investor had bought $100 of LULU stock 15 years ago, it would be worth $1,180.43 today based on a price of $254.24 for LULU at the time of writing.
<h3>Lululemon Athletica's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745277310_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LULU

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Three major U.S. defense contractors — RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>), Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) and Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) — are all scheduled to report earnings before the market opens on Tuesday. Here's a look at what to <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44810625/top-analyst-sees-unprecedented-traction-for-pltr-stock-after-nato-agreement-another-validation-sign">watch in the reports. </a>
What To Know: The Trump administration has signaled potentially historic defense spending, with reports suggesting a Pentagon budget near $1 trillion, which could benefit all three contractors. However, President Donald Trump has sent mixed messages by advocating for increased allied purchases of U.S. weapons while discussing the possibility of cutting U.S. military spending. 
The administration's push for efficiency, led by Elon Musk at the Department of Government Efficiency, introduces more uncertainty for defense contractors, as many major programs are under review. 
Read Next: <a href="https://www.benzinga.com/25/04/44903087/amazon-stock-downgraded-price-target-slashed-as-tariffs-create-uncertainty">Amazon Stock Downgraded, Price Target Slashed As Tariffs Create Uncertainty&nbsp;</a>
RTX: Investors will be looking for continued growth in RTX's Collins Aerospace and Pratt &amp; Whitney units, which both recently announced a slew of <a href="https://www.benzinga.com/news/contracts/25/04/44686376/rtx-pops-as-pratt-whitney-expands-gtf-capacity-collins-aerospace-enhances-offerings">new deals </a>and led 2024's gains.
The company's backlog will also be monitored for continued growth after reaching a record $218 billion at the end of 2024.&nbsp;
According to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, analysts expect the company to report earnings of $1.35 per share and revenue of $19.79 billion for the quarter.&nbsp;
NOC: Investors will be watching the performance of Northrop&#8217;s four main business segments: Aeronautics Systems, Defense Systems, Mission Systems and Space Systems, as well as updates on 2025 revenue and free cash flow guidance. 
Current expectations are for revenue between $42 billion and $42.5 billion and free cash flow of between $2.9 billion and $3.3 billion.&nbsp;
Earlier in April, Goldman Sachs analyst Noah Poponak upgraded Northrop Grumman stock from Sell to Neutral and raised the price target from $424 to $521. Analysts expect the company to report earnings of $6.26 per share on revenue of $9.94 billion, according to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>. 
LMT: Last week, Evan Scott <a href="https://www.benzinga.com/25/04/44867490/evan-scott-takes-over-as-lockheed-martin-cfo-succeeding-jesus-jay-malave">was named </a>as Lockheed Martin's CFO, succeeding Jesus Malave, effective immediately. In a press release, the company said it will be reaffirming its previously issued 2025 guidance and will provide updates on other key topics and answer questions with its first quarter earnings release. 
Investors will be watching the company's Aeronautics segment, driven by the F-35 program, which is expected to post solid sales. Analysts expect Lockheed Martin to report earnings of $6.34 per share on revenue of $17.8 billion for the first quarter. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/global/25/04/44899617/90-chance-of-recession-due-to-trumps-tariffs-sharp-slowdown-is-coming-economist-says">90% Chance Of Recession Due To Trump&#8217;s Tariffs: &#8216;Sharp Slowdown&#8217; Is Coming, Economist Says</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/MCMEDIASTUDIOPRO">MC MEDIASTUDIO</a> via Shutterstock

Previews

RTX, Lockheed Martin, Northrup Grumman Report Earnings Tuesday: What To Watch

Some startups break the internet. Others go old school—and still make a fortune.
Ari Siegel, the founder of History By Mail, has proven that even in the age of TikTok and <a href="https://www.benzinga.com/news/25/03/44375147/smart-puppies-are-smarter-than-ai-mark-cubans-surprising-take-on-the-future-of-artificial-intelligence">AI</a>, people still crave the tangible. His company ships replicas of historical documents—complete with authentic-looking paper and calligraphy—straight to subscribers&#8217; mailboxes each month.&nbsp;
<a href="https://www.nbcphiladelphia.com/news/business/money-report/38-year-old-brings-1-million-a-year-snail-mail-company-to-shark-tank-mark-cuban-you-dont-really-need-our-help/4155285/?os=wtmb5utKCxk5refapp6koVwAmR&amp;ref=app#:~:text=History%20By%20Mail%20brought%20in,as%20a%20U.S.%20Senate%20intern.">NBC10 Philadelphia</a> reported that the five-year-old business pulled in more than $1 million in revenue in 2024, and after a recent "Shark Tank" appearance, it had its biggest sales week ever.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
</ul>
<h2 class="wp-block-heading">From Senate Intern to History Entrepreneur</h2>
The idea was born when Siegel interned for the U.S. Senate and visited the Library of Congress. There, he spotted a letter penned by Abraham Lincoln and got inspired to replicate historical artifacts for friends and family. The emotional response he received sparked a business.
He launched History By Mail in January 2019. Early subscribers received documents every two weeks, each tied to major events or iconic figures in American history. But that fast pace quickly became a problem.
"People told us they loved the content, but couldn't keep up," Siegel told <a href="https://www.cnbc.com/2025/04/08/mark-cuban-shark-tank-company-history-by-mail-doesnt-need-help.html">CNBC "Make It."</a> It takes time to really dig into each letter. Everyone's busy." So, the company pivoted to monthly shipments—one letter, one context page, one manageable dose of history.
Trending: <a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy">This investment company boasts a 33.85% internal rate of return (IRR) for its realized projects, allowing accredited investors to earn passive returns and avoid the headaches of being a landlord.</a>
The simplicity worked. Siegel shared on "Shark Tank" that the company hit $1 million in revenue last year, without outside investment—until now. On the April 4 <a href="https://abc.com/episode/2e5d5998-9d1b-40ca-9f19-c8f12802544e/playlist/PL554912060">episode</a> of "Shark Tank," Siegel pitched the company and asked for $250,000 in exchange for 10% equity. His goal: scale the business through better social media marketing.
<a href="https://www.benzinga.com/startups/25/01/43084861/mark-cubans-29-million-shark-tank-portfolio-from-200k-in-dude-wipes-to-200m-for-beatbox-beverages-im-killing-it">Mark Cuban</a> praised the concept, telling Siegel, "You get to do what you love, and you're making a killing." Cuban and Lori Greiner passed on investing. Kevin O'Leary and Daniel Lubetzky each offered $250,000 for 20%, while Barbara Corcoran later jumped in to team up with Lubetzky. Together, they offered $125,000 each for a combined 20% stake.
Siegel accepted the offer from Lubetzky on air. However, a History By Mail spokesperson later confirmed to CNBC that only Lubetzky's firm, Camino Partners, finalized the deal. Corcoran was not part of the deal.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
According to CNBC, the "Shark Tank effect" was almost instantaneous. Sales hit a record high within an hour of the episode airing, the company confirmed. While no specific revenue numbers were shared, Siegel said it was the company's strongest sales week to date.
"We want to make historical documents more accessible," Siegel said. "They already belong to the public—they're just not in their hands."
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
Image: Shutterstock

Mark Cuban Said 'You're Making A Killing'—Then This Founder's History Startup Made $1 Million And Had Its Best Week Ever

ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) has outperformed the market over the past 10 years by 2.34% on an annualized basis producing an average annual return of 11.63%. Currently, ON Semiconductor has a market capitalization of $14.64 billion. 
Buying $1000 In ON: If an investor had bought $1000 of ON stock 10 years ago, it would be worth $2,997.41 today based on a price of $34.73 for ON at the time of writing.
<h3>ON Semiconductor's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745276415_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Pope Francis has <a href="https://www.benzinga.com/news/25/04/44892537/pope-francis-first-south-american-pontiff-and-peoples-pope-dies-at-88">died at the age of 88</a> leaving a vacancy for the position of the global head of the Catholic Church.
Here's a look at the betting odds for the next pope and why sports bettors believe one Major League Baseball player will hit a home run Monday.
Next Pope Odds: Pope Francis was the first South American pope and was known to many as the "People's Pope" thanks to his advocacy for the poor.
Francis had been pope since 2013 when Pope Benedict XVI resigned.
With the death of Pope Francis, the Conclave, a process to select the next pope, will now take place. Conclave typically happens between 15 and 20 days following the death of the pope, which includes a week of mourning.
Unlike presidents and world leaders, the new pope will not be selected by the public, but instead by a group of cardinals who are under the age of 80. The next pope will likely be a cardinal given past history, but all baptized Catholic males are eligible to become a pope.
Betting on the next pope is currently not allowed in the U.S., but prediction markets and European sportsbooks have odds listed after Monday's news of the pope's passing.
Here are the current betting odds for the next pope from prediction market <a href="https://polymarket.com/markets?_q=pope">Polymarket</a>:
<ul>
<li>Pietro Parolin (Italy): 36%</li>
<li>Luis Antonio Tagle (Philippines): 26%</li>
<li>Peter Erdo (Hungary): 8%</li>
<li>Peter Turkson (Ghana): 7%</li>
<li>Robert Sarah (Guinea): 5%</li>
<li>Matteo Zuppi (Italy): 5%</li>
<li>Raymond Burke (U.S.): 4%</li>
<li>Pierbattista Pizzaballa (Italy): 3%</li>
</ul>
Polymarket also has odds for the continent the winner will be selected from with the current odds:
<ul>
<li>Europe: 62%</li>
<li>Asia: 22%</li>
<li>Africa: 10%</li>
<li>North America: 3%</li>
<li>South America: 1%</li>
<li>Oceania: 1%</li>
</ul>
The prediction market also has odds for when the next pope will be announced, with only a 1% chance that the announcement comes by the end of April. The odds of a new pope announcement by May 9 sit at 59%, with the odds of a new pope revealed by May 31 at 97%.
Dating back to 1963, here are the number of days it took for the next pope to be announced:
<ul>
<li>2013: 13 days</li>
<li>2005: 17 days</li>
<li>1978: 18 days</li>
<li>1978: 20 days</li>
<li>1963: 18 days</li>
</ul>
Polymarket allows users to deposit funds using USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) via the Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/matic/usd">MATIC</a>) network or directly from a crypto account with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>). Winning wagers cash out at $1 per contract. Many of the pope markets have a deadline of Dec. 31, 2025, to cash out or they will turn to $0.
At <a href="https://www.oddschecker.com/us/insight/specials/politics/20250413-next-pope-odds-who-will-take-over-in-vatican-after-passing-of-pope-francis">Oddschecker</a>, the current favorites to be the next pope are:
<ul>
<li>Parolin +350, 22% chance</li>
<li>Tagle: +500, 17% chance</li>
<li>Angelo Scola (Italy): +700, 13% chance</li>
<li>Marc Ouellet (Canada): +700, 13% chance</li>
</ul>
Both Polymarket and Oddschecker show Parolin and Tagle as the favorites, while it could be anyone's guess beyond the two frontrunners before the Conclave begins. Tagle could become the first Filipino pope in history and the first pope from Asia in over 1,000 years.
Parolin has been Francis' secretary of state since 2014 and would likely continue his predecessor's style of leading while also bringing an Italian back to the leadership role after three straight non-Italian popes.. At the age of 67, Tagle could be considered young for a pope and could serve in the leadership role for decades.
Read Also: <a href="https://www.benzinga.com/news/24/09/40864360/pope-francis-criticizes-both-trump-and-kamala-harris-for-supporting-abortion-urges-catholics-to-vote">Pope Francis Criticizes Both Trump And Kamala Harris For Supporting Abortion, Urges Catholics To Vote For &#8216;Lesser Evil&#8217;</a>
MLB Pope Death Connection: Bettors on MLB games and player props are paying close attention to Nick Castellanos and the Philadelphia Phillies who battle the New York Mets Monday night at 7:10 p.m. ET.
Those familiar with baseball know that Castellanos has a knack for hitting home runs on days that have major global events or while the announcers are discussing controversial topics.
Castellanos began the day at odds of +750 to hit a home run at DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) and the odds have since fallen to +360 with a large number of bets being placed on the MLB hitter.
At BetMGM, Castellanos is the most bet player to hit a home run by more than 3x, <a href="https://x.com/johnewing/status/1914311584815485184">according </a>to John Ewing.
At ESPN Bet, Castellanos home run is the most bet player prop across MLB, NBA and NHL <a href="https://x.com/ButlerBets/status/1914390554948890805">combined</a>, which includes multiple Monday playoff contests.
Here is a list of <a href="https://www.inquirer.com/phillies/nick-castellanos-home-run-meme-biden-trump-20240722.html">examples </a>of when Castellanos has hit home runs:
<ul>
<li>The day Osama Bin Laden was killed</li>
<li>Right before Joe Biden dropped out of the 2024 presidential election</li>
<li>While a broadcaster was apologizing for using a homophobic slur</li>
<li>20th anniversary of the September 11 terrorist attacks (Sept. 11, 2021)</li>
<li>During a broadcaster's tribute to those who made "the ultimate sacrifice" on Memorial Day</li>
<li>Day of the assassination attempt on Donald Trump</li>
</ul>
As the Philadelphia Inquirer points out, Castellanos was on the injured list after Queen Elizabeth II died, so he was unable to keep his tradition of hitting home runs during global events in place. Time will tell if the pope's death is followed by a home run by Castellanos or if sportsbooks clean up from the large number of bets placed on the player prop.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44861571/donald-trump-blasts-too-late-and-wrong-fed-chair-powell-but-polymarket-traders-doubt-his-termination-will-come-fast-enough">Donald Trump Blasts &#8216;Too Late And Wrong&#8217; Fed Chair Powell, But Polymarket Traders Doubt His &#8216;Termination&#8217; Will Come &#8216;Fast Enough&#8217;</a></li>
</ul>
Photo: Shutterstock

Entertainment

Sports Betting

Sports

$ETH

$MATIC

$USDC

DKNG

USDC

Betting Odds For Pope Francis Replacement Show Two Favorites, Plus This Global Event Has MLB Bettors Backing Nick Castellanos To Hit Home Runs

Pan American Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAAS#NYSE">PAAS</a>) has outperformed the market over the past 10 years by 1.48% on an annualized basis producing an average annual return of 10.77%. Currently, Pan American Silver has a market capitalization of $9.77 billion. 
Buying $100 In PAAS: If an investor had bought $100 of PAAS stock 10 years ago, it would be worth $283.89 today based on a price of $26.97 for PAAS at the time of writing.
<h3>Pan American Silver's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745275512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PAAS

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

<a href="https://www.benzinga.com/personal-finance/25/04/44723566/charlie-munger-gave-his-no-1-tip-for-a-long-and-happy-life-avoid-crazy-at-all-costs-but-watch-out-crazy-is-way-more-common-than-you-think">Charlie Munger</a> wasn't just Warren Buffett's right-hand man—he was a billionaire in his own right, a master of patience, and a straight shooter when it came to wealth-building.&nbsp;
For decades, Munger dished out life lessons and money advice like a guy who knew the cheat codes. And he did. When you work shoulder to shoulder with the greatest investor of all time, people tend to lean in when you talk.
One of his final gems came on the <a href="https://www.acquired.fm/episodes/charlie-munger">"Acquired" podcast</a> in October 2023. Munger, sharp as ever in his final months, made it sound almost simple:
"The beauty of it is: <a href="https://www.benzinga.com/personal-finance/24/07/39842841/charlie-munger-said-getting-rich-is-harder-than-ever-but-heres-the-beauty-of-it-you-only-have-to">you only have to get rich once</a>."
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
He wasn't talking about luck. He wasn't pitching get-rich-quick nonsense. He was saying: do the work, build the foundation, and once you're there—you can stop grinding and let the compounding do the heavy lifting.
Munger also made it painfully clear that the beginning is the toughest part. Back in the late ‘90s at a Berkshire Hathaway meeting, he put it bluntly:
"The first $100,000 is a b&#x2A;tch, but you gotta do it. I don't care what you have to do—if it means walking everywhere and not eating anything that wasn't purchased with a coupon, find a way to get your hands on $100,000."
That $100,000 is equivalent to about $200,000 today when adjusted for inflation. So yes, the bar's higher now—but the principle still holds.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
Munger's reasoning? Once you've crossed that first financial threshold, wealth begins to build itself. That initial $100K isn't just a number—it's momentum. It's proof you can delay gratification, make smart choices, and keep money working for you instead of the other way around.
Compound interest becomes your new best friend.
When you invest that first $100,000 wisely, it starts to generate returns. Those returns earn more returns. The snowball effect kicks in, and before you know it, your money's doing more work than you are. But none of that happens if you don't push through that first stretch.
Of course, it's not just about math—it's about mindset.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
Here are the psychological roadblocks most people hit before even getting started:
Fear of losing money: The stock market can feel like a casino if you don't know what you're doing. But letting inflation quietly eat away at your savings in a checking account? That's a guaranteed loss.
Doubt: If you don't believe wealth is possible for you, you'll never bother trying. Munger's advice wasn't just for the Ivy League elite. It was for anyone willing to hustle and stick with it.
And while Munger didn't <a href="https://www.benzinga.com/personal-finance/25/04/44854326/warren-buffett-surpasses-bill-gates-with-165-billion-fortune-berkshire-is-a-stable-ship-in-a-sea-of-uncertainty">spell out every step to getting rich</a>, he left behind a trail of practical wisdom: live below your means, invest early, and don't get distracted by noise.
The goal isn't to get rich overnight. It's to get there once—and let that be enough.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy">This investment company boasts a 33.85% internal rate of return (IRR) for its realized projects, allowing accredited investors to earn passive returns and avoid the headaches of being a landlord.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Charlie Munger Said 'You Only Have To Get Rich Once' — But Warned The First $100K Is a 'B*tch' And The Most Important Step To Building Wealth

Antero Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>) has outperformed the market over the past 5 years by 57.45% on an annualized basis producing an average annual return of 70.12%. Currently, Antero Resources has a market capitalization of $9.98 billion. 
Buying $100 In AR: If an investor had bought $100 of AR stock 5 years ago, it would be worth $1,470.64 today based on a price of $32.06 for AR at the time of writing.
<h3>Antero Resources's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745273712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Antero Resources 5 Years Ago Would Be Worth This Much Today

SMBC

Southern Missouri Bancorp Reports Preliminary Results For Q3; Expects Q3 EPS $1.39 Vs $1.29

Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Gartner, presenting an average target of $508.0, a high estimate of $605.00, and a low estimate of $401.00. A decline of 8.93% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272862_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Gartner's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Manav Patnaik &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $475.00&#x7C;$510.00 &#x7C; 
&#x7C;Jason Haas &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Underweight &#x7C; $401.00&#x7C;$488.00 &#x7C; 
&#x7C;Manav Patnaik &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $510.00&#x7C;$600.00 &#x7C; 
&#x7C;Joshua Chan &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $500.00&#x7C;$565.00 &#x7C; 
&#x7C;Jeffrey Meuler &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $557.00&#x7C;$605.00 &#x7C; 
&#x7C;Jeffrey Meuler &#x7C;Baird &#x7C;Raises &#x7C;Outperform &#x7C; $605.00&#x7C;$579.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Gartner. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Gartner compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Gartner's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Gartner's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/IT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Gartner analyst ratings.</a>
<h2>All You Need to Know About Gartner</h2>
Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.
<h3>Understanding the Numbers: Gartner's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Gartner displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 8.13%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Gartner's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 23.24%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Gartner's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 32.89%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 4.87%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.13, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 6 Analysts Discuss Gartner Stock

Jones Trading analyst Jason Weaver maintains Dynex Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DX#NYSE">DX</a>) with a Buy and lowers the price target from $13.25 to $12.5.

Jones Trading Maintains Buy on Dynex Cap, Lowers Price Target to $12.5

Press Releases

Cullinan Therapeutics to Present Preclinical Data for CLN-978, a CD19-directed T Cell Engager, at ACR Convergence 2024

Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference

Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

Clear Street Launches Healthcare & Biotechnology Equity Research

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy

Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis

Comments

Cullinan Therapeutics

ニュース

最新ニュース Cullinan Therapeutics (NASDAQ:CGEM) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル